肥胖相关的阿尔多斯特主义与心脏结构,功能和肥胖的不良影响有关
medRxiv : the preprint server for health sciences
|November 26, 2025
概括
与肥胖相关的阿尔多斯特隆症在高血压成年人中很常见,并且与心脏问题和内脏脂肪增加有关. 这表明过多的阿尔多素可能会导致与肥胖有关的心脏病.
科学领域:
- 心脏病学 心脏病学
- 内分泌学 在内分泌学.
- 代谢综合征是代谢综合征的一种.
背景情况:
- 与肥胖相关的阿尔多斯特隆症可能会增加心脏代谢风险.
- 研究了肥胖的高血压成年人中阿尔多素失调和心脏代谢结果之间的联系.
研究的目的:
- 调查失调的阿尔多素生产与心脏结构,功能和脂肪性之间的关联.
- 在受控的生理条件下,评估肥胖的高血压成年人的阿尔多素产量.
主要方法:
- 预期招募肥胖高血压参与者.
- 通过四种受控的生理机动 (SST,OSLT,DST,ACTH刺激) 进行阿尔多素生产的全面表型化.
- 心脏和腹部MRI用于评估心脏结构,功能,心脏脂肪,肝脏脂肪以及内脏和皮下脂肪的比例.
主要成果:
- 29.2%的参与者有明显的原发性阿尔多斯特主义.
- 较高的阿尔多素水平与左心室质量指数增加,全球纵向应变受损,心脏脂肪体积和内脏与皮下脂肪比率相关.
- 在不同的阿尔多激素刺激/抑制测试中,相关性是一致的.
结论:
- 失调的阿尔多素生产和原发性阿尔多素主义在肥胖的高血压成年人中很普遍.
- 这些情况独立地与不良的心脏重塑和心脏代谢脂肪组织增加有关.
- 研究结果表明,阿尔多激素过量与与肥胖有关的心脏代谢疾病之间存在病理生理学联系.
相关概念视频
01:24Obesity
1.1K
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.1K
01:29Heart Failure II: Pathophysiology
693
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
693
01:27Adrenal Gland Disorders
2.8K
Adrenal gland disorders manifest when the production of adrenal hormones deviates from the norm, resulting in either excessive or insufficient concentrations.
Adrenal insufficiency, characterized by insufficient cortisol and aldosterone production, leads to conditions like Addison's disease. This disorder, affecting the adrenal cortex, exhibits symptoms such as skin bronzing, dehydration, low blood pressure, fatigue, and weight loss. Congenital adrenal hyperplasia, a genetic ailment causing...
Adrenal insufficiency, characterized by insufficient cortisol and aldosterone production, leads to conditions like Addison's disease. This disorder, affecting the adrenal cortex, exhibits symptoms such as skin bronzing, dehydration, low blood pressure, fatigue, and weight loss. Congenital adrenal hyperplasia, a genetic ailment causing...
2.8K
01:33Hormonal Regulation
35.6K
The renin-aldosterone system is an endocrine system which guides the renal absorption of water and electrolytes, thus managing blood pressure and osmoregulation. Activation of the system begins in the kidneys with a small cluster of cells adjacent to the afferent and efferent blood vessels of the renal corpuscle. As the nephrons are filtering blood, juxtaglomerular cells monitor blood pressure. If they detect a decrease in pressure, they release the hormone renin into the bloodstream.
35.6K
01:30Coronary Artery Disease I: Introduction
857
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
857
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
895
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
895